Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Thoracic 1Gynecologic 1Genitourinary 1Dermatologic 1

Conditions

Ovarian Neoplasms 1Melanoma 1Kidney Neoplasms 1Childhood Cancer Survivors 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1238Docetaxel 1227Oxaliplatin 1184Capecitabine 1178Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 899Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 640Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Dried Blood Spot Testing × Clear all
NCT07009288 2026-05-27

A Study of Time-Restricted Eating in Childhood Cancer Survivors

Memorial Sloan Kettering Cancer Center

Phase NA Recruiting
300 enrolled

Childhood Cancer Survivors

NCT04154163 2022-02-28

ADOPT

University of Dundee

Completed
18 enrolled
DermatologicGenitourinaryGynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Kidney Neoplasms, Melanoma, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡